India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.
Read full Post
Subscribe to:
Post Comments (Atom)
Powered by Blogger.
Translate
Blog Archive
-
►
2024
(488)
- August (5)
- July (78)
- June (68)
- May (78)
- April (75)
- March (73)
- February (32)
- January (79)
-
►
2023
(1056)
- December (79)
- November (73)
- October (92)
- September (107)
- August (96)
- July (87)
- June (99)
- May (93)
- April (72)
- March (93)
- February (83)
- January (82)
-
►
2022
(1533)
- December (96)
- November (95)
- October (95)
- September (88)
- August (132)
- July (122)
- June (153)
- May (142)
- April (138)
- March (154)
- February (137)
- January (181)
-
►
2021
(5903)
- December (379)
- November (671)
- October (680)
- September (670)
- August (713)
- July (713)
- June (379)
- May (308)
- April (364)
- March (403)
- February (346)
- January (277)
-
▼
2020
(7257)
- December (256)
- November (315)
- October (488)
- September (689)
- August (713)
- July (713)
- June (693)
- May (713)
- April (684)
- March (718)
- February (660)
- January (615)
Search
Contact Form
Designed with by Way2Themes | Distributed By Best Blogger Themes
No comments:
Post a Comment